Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|February 11, 2010
LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivatorsYusuke Mita, Kosuke Dodo, Tomomi Noguchi-Yachide, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 25, 2017
1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulatorsKaori Endo-Umeda, Atsushi Aoyama, Masato Shimizu, et al.
Bioorganic & Medicinal Chemistry|September 4, 2016
Discovery of N-(1-(3-(4-phenoxyphenyl)-1,2,4-oxadiazol-5-yl)ethyl)acetamides as novel acetyl-CoA carboxylase 2 (ACC2) inhibitors with peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonistic activityShogo Okazaki, Tomomi Noguchi-Yachide, Taki Sakai, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Phenanthridin-6-one derivatives as the first class of non-steroidal pharmacological chaperones for Niemann-Pick disease type C1 proteinHiromitsu Fukuda, Fumika Karaki, Kosuke Dodo, et al.
Bioorganic & Medicinal Chemistry|March 1, 2006
Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: preliminary control of alphavbeta3 selectivity by meta-oriented substitutionDai Kubota, Minoru Ishikawa, Midori Ishikawa, et al.
Bioorganic & Medicinal Chemistry|November 29, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonistsMinoru Ishikawa, Dai Kubota, Mikio Yamamoto, et al.
Bioorganic & Medicinal Chemistry|November 26, 2005
Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubilityMinoru Ishikawa, Yukiko Hiraiwa, Dai Kubota, et al.
Journal of the American Chemical Society|April 27, 2021
Proximity Histidine Labeling by Umpolung Strategy Using Singlet OxygenKeita Nakane, Shinichi Sato, Tatsuya Niwa, et al.
FEBS Letters|March 19, 2011
Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target proteinKeiichiro Okuhira, Nobumichi Ohoka, Kimie Sai, et al.
Chemistry, an Asian Journal|July 6, 2016
Improvement in Aqueous Solubility of Retinoic Acid Receptor (RAR) Agonists by Bending the Molecular StructureMichiaki Hiramatsu, Yuki Ichikawa, Shusuke Tomoshige, et al.
Pageof 8